Skip to main content
. 2022 Sep 12;13:906468. doi: 10.3389/fphar.2022.906468

FIGURE 3.

FIGURE 3

C1 and its combination with sorafenib demonstrated inhibitory effects on HCC cell line in CCK-8 analysis and induced cellular senescence. HCC cells were treated with C1 and its combination with sorafenib and (A) 24 h and (B) 48 h after incubation cells were subjected to CCK-8 analysis at OD450. Shown are mean ± SEM with *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. (C) SA-β-Gal assay was performed 48 h post-incubation in C1-treated group. Shown are representative bright field microscopy pictures (objective ×40). Senescent (blue) cells are depicted with white arrows.